All Access Pass - 1 FREE Month!
Institutional email required, no credit card necessary.

Conjunctivitis

Overview
Basic Pathogenesis
Conjunctival inflammation of the the inner eyelids (the tarsal conjunctiva) and the sclera (the “white of the eye”, which is the bulbar conjunctiva).
Etiology
Conjunctivitis can be secondary to a variety of causes, which we divide into infectious and non-infectious.
Infectious Causes
Bacterial conjunctivitis
  • Prominent feature is purulent “mucus” consistency discharge (yellow, green, or white).
  • Unilateral or bilateral in distribution.
  • 7 – 10 day course.
  • Highly contagious.
  • Typically occurs in the Winter/Spring (December to April).
  • Key bacteria include -
    • Adults: Staphylococcus aureus (and less often Streptococcus pneumoniae, Haemophilus influenzae).
    • Children: Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis.
    • Critically ill: Pseudomonas aeruginosa
    • Newborns (via oculogenital transmission): Neisseria gonorrheae and Chlamydia trachomatis
    • Contact Wearers: Pseudomonas aeruginosa is a notable cause. As well, be aware that the risk of Acanthamoeba keratitis (a vision-threatening infection) is increased by contact use.
Trachoma
  • Chlamydia trachomatis, the worldwide leading infectious cause of blindness, is a keratoconjunctivitis secondary to recurrent Chlamydia trachomatis infection. The infection typically occurs in children in endemic areas via direct or indirect transmission of ocular or nasal secretions (the microorganism collects on a person’s fingers, on an inanimate object (fomite), or on a fly and is transmitted to another individual’s eyes).
  • Note that trachoma manifests as active conjunctivitis (active trachoma) and ultimately can result in conjunctival scarring (cicatricial disease), which is secondary to recurrent infection and a type 4 hypersensitivity response (cell-mediated delayed hypersensitivity).
  • Note that Chlamydia trachomatis produces 3 forms of eye infection (trachoma is just one of them). The other two are:
    • Neonatal conjunctivitis occurs when a newborn (in the first 15 days of life) is infected from vagina of an infected mother during delivery.
    • Adult inclusion conjunctivitis occurs in the setting of concomitant genitourinary tract infection.
Viral conjunctivitis
  • Adenoviral conjunctivitis is the prominent cause (~ 75% of cases).
  • Typically, part of an adenovirus infection with a upper respiratory infectious prodrome.
  • Copious, watery, mucoserous discharge with a “gritty” feeling in one eye and then the other eye becomes symptomatic within 1-2 days.
  • Highly contagious (transmissible).
    • Patients may report purulent discharge but this is usually actually crusting of serous discharge overnight giving a more purulent appearance in the morning.
  • Ocular viral conjunctivitis can be part of herpes infections, including:
    • Herpes simplex virus epithelial keratitis (HSV keratitis) can occur during initial infection or recurrent infection. Key pathological finding: “multiple small branching epithelial dendrites on the corneal surface”.
    • Herpes zoster ophthalmicus, which is shingles in the V1 distribution, which is typically extremely painful and can lead to corneal scarring.
NON-Infectious Causes
Allergic Conjunctivitis
  • Airbone allergens induce a type I IGE-mediated hypersensitivity response.
  • Bilateral pink (more-so than red) appearance.
  • “Velvety thickening” and Giant papillae on the inner eyelid, giving a cobblestone appearance.
  • Burning, itching, irritation, worsens with eye rubbing.
  • Associated allergy history.
  • Forms of allergic conjunctivitis:
    • Seasonal conjunctivitis due to seasonal allergen.
    • Atopic keratoconjunctivitis is a chronic (perennial), severe form.
    • Vernal keratoconjunctivitis is a chronic, severe form in a select climate: warm, dry, subtropical (eg, the Mediterranean).
    • Giant papillary conjunctivitis in contact wearers.
Toxic, Mechanical, or Chemical Conjunctivitis
  • Irritant-induced.
  • Typically, self-limited.
References
  • Azari, Amir A., and Neal P. Barney. “Conjunctivitis: A Systematic Review of Diagnosis and Treatment.” JAMA 310, no. 16 (October 23, 2013): 1721–29. https://doi.org/10.1001/jama.2013.280318.
  • Chen, Yu-Yen, Su-Hsun Liu, Ulugbek Nurmatov, Onno Cp van Schayck, and Irene C. Kuo. “Antibiotics versus Placebo for Acute Bacterial Conjunctivitis.” The Cochrane Database of Systematic Reviews 3, no. 3 (March 13, 2023): CD001211. https://doi.org/10.1002/14651858.CD001211.pub4.
  • “Conjunctivitis - EyeWiki.” Accessed July 8, 2024. https://eyewiki.aao.org/Conjunctivitis#Viral_conjunctivitis.
  • Epling, John. “Bacterial Conjunctivitis.” BMJ Clinical Evidence 2012 (February 20, 2012): 0704.
  • Ibrahim, Youhanna W., David L. Boase, and Ian A. Cree. “Factors Affecting the Epidemiology of Acanthamoeba Keratitis.” Ophthalmic
Epidemiology 14, no. 2 (January 1, 2007): 53–60. https://doi.org/10.1080/09286580600920281.
  • Mishori, Ranit, Erica L. McCLASKEY, and Vince J. Winklerprins. “Chlamydia Trachomatis Infections: Screening, Diagnosis, and Management.” American Family Physician 86, no. 12 (December 15, 2012): 1127–32.
Image Reference
Conjunctivitis (side view) Conjunctivitis (front view)